Experimental therapy completely clears HPV in one-third of cervical cancer precursors

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.

Leave a Reply

Your email address will not be published. Required fields are marked *